JRX is a "macro molecule" delivery system and specialty biochemistry technology company. We are focused on developing and commercializing our DermX^TM MegasphereTM Delivery System - a novel and patented transdermal delivery system technology platform that has been independently proven to allow high molecular weight molecules to penetrate deep into human skin.

The company's DermX^TM MegasphereTM Delivery System is currently being used in a highly successful anti-wrinkle serum called Hydroderm, a product that has generated well over $100 million in retail sales to date.

JRX Biotech is looking to expand its technology partnership reach throughout the personal appearance products, cosmetics, Over-the-Counter (OTC), and prescription (Rx) industries. To execute on this strategy, JRX has brought together a team of successful executives, experienced chemists, and proven entrepreneurs.